Repair of DNA double-strand breaks (DSBs) by homologous recombination (HR) is critical for survival and genome stability of individual cells and organisms, but also contributes to the genetic diversity of species. A vital step in HR is MRN-CtIP-dependent end resection, which generates the 3 single-stranded DNA overhangs required for the subsequent strand exchange reaction. Here, we identify EXD2 (also known as EXDL2) as an exonuclease essential for DSB resection and efficient HR. EXD2 is recruited to chromatin in a damage-dependent manner and confers resistance to DSB-inducing agents. EXD2 functionally interacts with the MRN complex to accelerate resection through its 3 -5 exonuclease activity, which efficiently processes double-stranded DNA substrates containing nicks. Finally, we establish that EXD2 stimulates both short-and long-range DSB resection, and thus, together with MRE11, is required for efficient HR. This establishes a key role for EXD2 in controlling the initial steps of chromosomal break repair.
DNA double-strand breaks (DSBs) are extremely cytotoxic lesions that can arise during normal cellular processes or are induced by exogenous factors such as ionizing radiation (IR) as well as many commonly used anticancer drugs. The faithful repair of DSBs is essential for cell survival and organismal development, as defective repair can contribute to a plethora of inherited human syndromes with life-threatening symptoms including cancer, neurodegeneration or premature ageing 1,2 . The two major pathways involved in the repair of DSBs in eukaryotic cells are non-homologous end joining and homologous recombination (HR; refs [3] [4] [5] . A key initial step in HR is resection of the DNA ends on either side of the break, which is carried out initially by the MRE11-RAD50-NBS1 complex (MRN) and CtIP (also known as RBBP8, retinoblastoma binding protein 8) to generate short stretches of single-stranded DNA (ssDNA; refs [6] [7] [8] . Subsequently, the EXO1 (exonuclease 1) or DNA2 (DNA replication helicase/nuclease 2) nucleases, in conjunction with the Bloom syndrome helicase (BLM), extend these to generate longer 3 ssDNA tails [9] [10] [11] [12] [13] [14] [15] . These ssDNA strands are then bound by replication protein A (RPA; refs [10] [11] [12] [16] [17] [18] , which is subsequently replaced by RAD51 in a BRCA2 (breast cancer 2)-dependent manner, leading to the formation of ssDNA-RAD51 nucleoprotein filaments essential for the strand exchange process 3, 19 . In vitro, MRE11 displays a weak endo-and exonuclease activity, which may be due to the lack of accessory factors 16, 20 . Accordingly, work from multiple laboratories has shown that CtIP, or its yeast homologue Sae2 (sporulation in the absence of spo eleven), can stimulate MRE11's endonuclease activity 9, [16] [17] [18] . Interestingly, MRE11 has also been shown to nick the DNA strand to be resected in multiple positions, as far as 300 base pairs (bp) from the break itself, suggesting that resection could proceed from several entry points that are distal to the DSB (refs 21,22) . However, it is unclear whether this would enhance MRE11-dependent nucleolytic processing of DNA ends, thus generating a better substrate for subsequent processing of the break by BLM-DNA2 and/or BLM-EXO1 complexes, or allow access for additional factors accelerating the initial strand processing. Indeed, the inhibition of MRE11's endonuclease activity confers a stronger resection defect than inhibition of its exonuclease activity, suggesting perhaps that initial break processing might be also carried out by other exonucleases 23 . Here we identify EXD2 (exonuclease 3 -5 domain containing 2) as a cofactor of the MRN complex required for efficient DNA end resection, recruitment of RPA, HR and suppression of genome instability.
EXD2 is required for repair of damage to DNA
In an effort to identify factors required to promote HR, we carried out an unbiased proteomic approach to define the CtIP interactome. Here, we have identified EXD2, a largely uncharacterized protein with a putative exonuclease domain, as a candidate CtIP binding partner (Fig. 1a) . We validated this interaction by co-immunoprecipitations from human cell extracts and found that we could readily detect endogenous EXD2 by western blotting of green fluorescent protein (GFP)-CtIP immunoprecipitates (Fig. 1b) . Endogenous CtIP, as well as its known interactors MRE11 and BRCA1, were detected in reciprocal Flag-EXD2 immunoprecipitates ( Fig. 1c ; lysates were treated with Benzonase to prevent DNA bridging). Therefore, we conclude that the two proteins probably exist in the same complex in cells.
EXD2 is highly conserved across vertebrates (Supplementary Fig. 1 ) and was recently identified in the screen for suppression of sensitivity to mitomycin C (ref. 24) . However, the biological and biochemical features of this protein are unknown. As we identified EXD2 as an interactor of DSB-repair factors, we tested its requirement in response to a range of DSB-inducing agents, namely IR, camptothecin (CPT) and phleomycin. We found that depletion of EXD2 by two different short interfering RNAs (siRNAs) sensitized U2OS cells to these agents (Fig. 1d-f and Supplementary Fig. 2a,b) . Taken together, these results suggest a putative role for this protein in the repair of damaged DNA.
EXD2 promotes DNA end resection and the generation of ssDNA CtIP is essential for efficient DNA end processing during DSB repair, with cells depleted for this factor showing a defect in the generation of ssDNA and the subsequent formation of RPA foci 16, 25, 26 . Thus we hypothesized that EXD2 may promote DNA end resection. To test this, we analysed RPA focus formation in response to both CPT and IR in wild-type (WT) and EXD2-depleted cells. Strikingly, cells depleted for EXD2 showed severely impaired kinetics of RPA focus formation in response to both treatments (Fig. 2a,b and Supplementary Fig. 2c,d ). RPA2 phosphorylation at Ser4 and Ser8 has been widely used as a marker for the generation of ssDNA by DNA end resection 27 . Consistent with the data above, EXD2-depleted cells showed impaired RPA Ser4, Ser8 phosphorylation in response to DNA damage ( Fig. 2c and Supplementary Fig. 2e ). Treatment with both agents resulted in a robust phosphorylation of histone H2AX (also known as H2AFX) and CHK2 (also known as CHEK2) ( Fig. 2c and Supplementary Fig. 2e ), confirming induction of DNA damage in cells. Moreover, since these responses were intact in EXD2-depleted cells, EXD2 is most likely not required for initial sensing of the DNA damage. Failure to generate RPA foci could be associated either with a defect in exonucleolytic , 300 cells (EXD2 siRNA, untreated), 300 cells (control siRNA, 1 µM CPT) and 300 cells (EXD2 siRNA, 1 µM CPT), grouped from three independent experiments. Error bars represent ±s.e.m. The Chisquare test was used to determine statistical significance. (f) Chromatin fractionation of HeLa cells untreated or treated with 500 µM phleomycin for 1 h as indicated. γH2AX and RPA2 pSer4, Ser8 are used as markers of DNA damage and histone H3 acts as a loading control. This experiment was carried out twice independently. Unprocessed original scans of blots are shown in Supplementary Fig. 7 .
processing of the DSB into ssDNA, or with impaired recruitment of RPA itself to ssDNA. To distinguish between these two possibilities we tested the efficiency of ssDNA generation in EXD2-depleted cells exposed to DNA damage. To this end, we labelled cells with 5-bromodeoxyuridine (BrdU) and then employed immunofluorescence microscopy using an anti-BrdU antibody under non-denaturing conditions to detect stretches of ssDNA. Depletion of EXD2 significantly reduced formation of ssDNA foci (Fig. 2d,e) , suggesting impaired resection. This is reminiscent of the phenotype observed in cells depleted for essential components of DNA end resection machinery, such as MRE11 or CtIP (refs 6,16) . Importantly, these phenotypes were not due to changes in the cell cycle, as EXD2 depletion had little effect on the overall cell-cycle distribution profile ( Supplementary  Fig. 2f ). Despite multiple attempts, we were unable to visualize EXD2 recruitment to DNA damage foci. In this regard, we note that certain other proteins involved in DNA repair do not readily form cytologically discernible foci in mammalian cells, that is, Ku70, Ku80 or DNA2. However, EXD2 was recruited to chromatin in HeLa cells on DNA damage as assayed by subcellular fractionation (Fig. 2f) , supporting its putative role in the processing of DSBs. A similar recruitment was also observed for the key resection factor MRE11 (Fig. 2f) .
Taken together, these results indicate that EXD2 is a putative component of the resection machinery required for the efficient processing of DSBs. (n = 3 independent experiments). (e) Quantification of the frequency of chromosomal aberrations from mitotic spreads prepared from U2OS cells treated with control siRNA or an siRNA smartpool targeting EXD2 (EXD2 siRNA). Error bars represent ±s.e.m., n = 75 metaphase spreads pooled from three independent experiments. Statistical significance was determined using Student's t-test.
EXD2 promotes HR and suppresses genome instability
In vivo RPA is required for RAD51 focus formation, and in vitro it has been shown to promote RAD51-mediated strand exchange 28, 29 . Consistent with this, treatment of U2OS cells with IR generated large numbers of RAD51 foci (Fig. 3a,b) . In contrast, EXD2 depletion significantly impaired RAD51 focus formation (Fig. 3a,b) . RAD51-ssDNA nucleoprotein filament formation is a crucial step in DSB repair by HR (refs 30-32) . To examine if EXD2 is also required for efficient HR we used a U2OS cell line carrying an integrated HR reporter transgene and an I-SceI recognition sequence 33 . Transient expression of I-SceI endonuclease generates a DSB that, when repaired by HR, restores the expression of a functional GFP protein. We found that depletion of EXD2 significantly decreased the frequency of HR (Fig. 3c) . Cells defective in HR are intrinsically sensitive to poly ADP ribose polymerase (PARP) inhibitors 34 . Accordingly, EXD2 depletion sensitized cells to the PARP inhibitor olaparib (Fig. 3d) . Failure to efficiently repair damaged DNA is associated with chromosomal instability, and in line with this we found a significantly greater number of chromosomal aberrations in EXD2-depleted U2OS cells as compared with the WT control (Fig. 3e) . Taken together, these data support a role for EXD2 in promoting HR and genome stability.
Exonuclease activity of EXD2 facilitates the generation of ssDNA
The MRN complex processes DSBs to generate ssDNA, which requires MRE11's 3 -5 exonuclease activity 20, 35 . Interestingly, EXD2 has a predicted exonuclease fold, which has sequence homology to the 3 -5 exonuclease domain of the Werner syndrome protein (WRN). Analysis of the alignment between EXD2 and WRN identified two key amino acids (Asp 108 and Glu 110) within the putative exonuclease domain of EXD2, which are also highly conserved in other DnaQ type exonucleases, including WRN, that coordinate the binding of metal ions within the active site 36 ( Supplementary Fig. 3a) . Mutation of the equivalent residues in WRN (Asp 82 and Glu 84) renders the protein devoid of nuclease activity 37 . Therefore, we hypothesized that the equivalent residues in EXD2 may be also required for its putative nuclease activity. To test this, we expressed the full-length glutathione S-transferase (GST)-tagged EXD2 and the D108A and E110A mutant protein in bacteria, and purified them to apparent homogeneity ( Supplementary Fig. 3b ). Next, we tested the activity of these purified proteins on ssDNA radiolabelled on the 3 or 5 end (Fig. 4a,b ). We found that purified EXD2, but not the D108A and E110A mutant, exhibited a robust nuclease activity on short 5 labelled ssDNA (Fig. 4a) . Furthermore, a time course of the 3 labelled substrate digestion indicates that EXD2 degrades the labelled DNA strand from the 3 end, as evidenced by the release of the single labelled nucleotide (Fig. 4b ). This data shows that EXD2 displays a 3 -5 exonuclease activity in vitro. Moreover, under these conditions the WT protein exhibited only weak activity towards blunt end doublestranded DNA (dsDNA; Fig. 4c ). To verify this data, we also identified a highly soluble truncated form of EXD2 (spanning residues Lys76 through to Val564, containing the predicted exonuclease domain) that can be produced at very high yields and purity in a three-step procedure ( Supplementary Fig. 3c -e). This version of EXD2, and its D108A E110A variant, behaved indistinguishably from full-length EXD2 ( Supplementary Fig. 3f ). In addition, the protein showed only a weak activity towards dsDNA with a resected 3 end (Fig. 4d) , and did not display any endonuclease activity on ssDNA or dsDNA with a biotin/streptavidin-blocked 3 end (Fig. 4e) . Importantly, purified EXD2 displayed a robust exonuclease activity, which co-elutes with the protein (Fig. 4f ). Thus our data identify EXD2 as a bone fide exonuclease with a 3 -5 polarity.
To address the potential biological significance of EXD2's exonuclease activity, we tested whether this activity was required to promote DNA end resection in vivo. To this end, we examined the phenotypes of two independently derived U2OS clones stably expressing WT or the nuclease-dead (D108A and E110A) EXD2 mutant. The endogenous protein was depleted with siRNA targeting the 3 untranslated region (UTR) of EXD2 ( Supplementary Fig. 4a ). Notably, cells expressing the nuclease-dead protein did not correct P < 0.0001 P < 0.0001 P < 0.0001
Clone 1 Clone 2 Clone 1 Clone 2 . Cells were treated with 5 µg ml −1 phleomycin, and the resistance of cells transfected with control siRNA was set at 100% (n = 4 independent experiments). For all panels, bars represent mean ± s.e.m. Statistical significance was determined using the Chi-square test (a-c) or
phenotypes associated with EXD2 deficiency as compared with cells expressing WT EXD2 (Fig. 5a-d ). This result is consistent with our data showing a requirement for EXD2 in the processing of DSBs into ssDNA. Cells overexpressing WT EXD2 displayed elevated resection. In this regard we note that overexpression of WT MRE11 also increases resection efficiency, resulting in elevated levels of RPA focus formation and RPA phosphorylation 38 .
EXD2 cooperates with MRE11 in the repair of DSBs
The in vivo resection that initiates DSB repair is catalysed by the MRN complex 6, 7, 14, 39 . To test whether or not EXD2 collaborates in this process with MRE11 we analysed the kinetics of RPA focus formation (a marker of resection) in cells depleted for either of these proteins or concomitantly depleted for both EXD2 and MRE11. We found that combined depletion resulted in a comparable inhibition of resection as observed for depletion of MRE11 alone (Fig. 6a) . A similar relationship was also observed for RAD51 foci ( Supplementary Fig. 4b,c) . Interestingly, the defect observed in EXD2-depleted cells was slightly weaker than that observed in MRE11 alone, suggesting that MRE11 functions upstream of EXD2 in DNA resection, perhaps initiating resection through its endonuclease activity. Indeed, it has been suggested recently that MRE11 may create multiple nicks on the strand being resected that could serve as additional exonuclease entry sites to further enhance nucleolytic processing 21, 22 . We tested this notion in several ways. First, we analysed if MRN-dependent DNA resection is accelerated in the presence of EXD2. Purified EXD2 and the MRN complex (MRE11, RAD50, NBS1) were incubated together with circular single-stranded X174 DNA. This substrate requires initial endonuclease-dependent nicking by the MRN complex to undergo resection. As previously reported, the MRN complex exhibited nuclease activity under these conditions 16 (Fig. 6b) . Importantly, combining EXD2 with the MRN complex resulted in increased ssDNA degradation in vitro (Fig. 6b,c) . As expected, addition of exonucleasedead EXD2 protein to the MRN complex resulted in DNA degradation similar to that observed for MRN alone (Fig. 6b,c) . Second, we predicted that EXD2 should be able to initiate resection from a nicked and a gapped duplex substrate designed to mimic the substrates generated by MRE11 endonuclease activity during the initial stage of DNA end resection. Strikingly, EXD2 exhibited robust exonuclease activity on both the nicked and gapped substrates (Fig. 6d-f and Supplementary  Fig. 4d,e) . Taken together, these data show that EXD2 functionally collaborates with the MRN complex in promoting DNA degradation.
To gain more functional insight into the role of EXD2's exonuclease activity in DNA end resection in vivo, we took advantage of the recently developed small molecule inhibitors targeting the exo-or endonuclease activity of MRE11 (ref. 23) . Inhibition of MRE11 endonuclease activity resulted in almost total inhibition of resection, whereas cells treated with the MRE11 exonuclease inhibitor showed a milder resection defect (Fig. 7a) , as reported previously 23 . Knockdown of EXD2 alone resulted in a resection defect significantly stronger (p < 0.0001) than that observed in cells treated with the MRE11 exonuclease inhibitor alone. Depletion of EXD2 in the presence of the MRE11 exonuclease inhibitor did not decrease efficiency of resection further than was achieved with EXD2 depletion alone (Fig. 7a) . Interestingly, some residual resection was still observed in cells concomitantly depleted for EXD2 and incubated with the MRE11 exonuclease inhibitor, indicating either an involvement of another exonuclease in this step of DNA end processing 23 or that EXD2 knockdown or MRE11 exonuclease inhibition was not complete. Nevertheless, these data suggest that both the exonuclease activity of EXD2 and that of MRE11 function within the same pathway and are required for efficient DNA end resection. Knockdown of EXD2 in cells treated with an inhibitor targeting MRE11's endonuclease activity showed a similar resection defect when compared with the inhibitor alone (Fig. 7a) , supporting the notion that EXD2 functions downstream of MRE11's endonuclease activity.
Next, we asked which part of the resection process, that is, short-range versus long-range resection, is affected in cells depleted for EXD2. To test this, we depleted EXD2 in a cell line allowing for the induction of a DSB in a specific genomic locus in vivo 40 . Then we analysed the efficiency of DNA resection at this DSB by quantitative PCR (qPCR) at two positions: one located close to the break (335 bp downstream of the break-short-range resection) and the other located at 1,618 bp from the break (long-range resection; ref. 40) . Interestingly, we found that EXD2 depletion affected both short-range and long-range resection (Fig. 7b,c and Supplementary  Fig. 4f ). Knockdown of MRE11 resulted in a similar albeit stronger resection phenotype, thus providing further evidence to support its upstream function in this process. Importantly, concomitant depletion of both proteins did not further potentiate the resection defect.
Given that both EXD2 and MRE11 regulate DSB resection, we tested the effect of their combined depletion on HR using the DR-GFP assay. In support of their role in this process, we observed that combined depletion of EXD2 and MRE11 did not decrease HR efficiency further than observed in the single knockdowns ( Fig. 6d and Supplementary Fig. 4g ).
These findings therefore show that EXD2 promotes DNA end resection and HR by enhancing the generation of ssDNA through a common mechanism with the MRN complex. Furthermore, it seems likely that MRE11 functions upstream of EXD2 in this process, probably initiating resection through its endonuclease activity.
To verify and extend the above conclusions, we used CRISPR/Cas9 nickase based gene editing 41 in HeLa cells to generate EXD2 −/− clones ( Supplementary Fig. 5a ). The use of Cas9 nickase has been recently shown to minimize any off-target effects 42 . Comparable to siRNA-treated U2OS cells, EXD2 −/− HeLa cells showed dramatically decreased RPA focus formation in response to CPT ( Supplementary Fig. 5b,c) , diminished RPA2 phosphorylation on Ser4, Ser8 (Supplementary Fig. 5d ) and decreased survival in response to CPT (Supplementary Fig. 5e ). We also tested if EXD2 depletion affects the MRE11 or CtIP protein stability and/or their recruitment to DSBs. We found this not to be the case, as cells lacking EXD2 had similar levels of endogenous MRE11 or CtIP to the WT control ( Supplementary Fig. 5f ). Likewise, MRE11 or GFP-CtIP localization to DSBs induced by microirradiation 43 was not affected ( Supplementary Fig. 6a-c) . These findings therefore establish EXD2 as an important regulator of DSB resection.
DISCUSSION
We have shown that EXD2 facilitates DSB resection, thus promoting recruitment of RPA and HR. Accordingly, cells depleted for EXD2 show spontaneous chromosomal instability and are sensitive to DNA damage induced by agents that generate DSBs. Furthermore, we establish that EXD2 functionally interacts with the MRN complex, utilizing its 3 -5 exonuclease activity to accelerate DSB resection and promote efficient HR. In line with this, complementation experiments showed that exonuclease-dead mutant protein failed to complement these phenotypes. Interestingly, EXD2 seems to be dispensable for the initial sensing of the break, as evidenced by efficient γH2AX and CHK2 phosphorylation, and most likely acts downstream of MRE11. Finally we reveal that both EXD2 and MRE11 function in the same pathway for DSB resection and HR. It is unclear at present why cells would need two exonucleases with the same polarity. However, a paradigm for such a requirement is evident from the fact that cells have two alternative machineries, consisting of BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN, that carry out long-range resection 9, 10, 13, 44 . Thus, by analogy EXD2 may function together with MRE11 to accelerate resection in the 3 -5 direction to efficiently produce short 3 ssDNA overhangs. This could promote faster generation of longer stretches of ssDNA, which in turn may serve as a better substrate for BLM-DNA2 or BLM-EXO1 to initiate long-range resection. Accordingly, depletion of EXD2 adversely impacts on this process. Ultimately, efficient generation of ssDNA with minimal homology length required for productive HR would suppress unscheduled deleterious recombination events. This may be particularly important in vertebrates, as they require significantly longer stretches of ssDNA (200-500 bp) to initiate productive HR (ref. 45) , in contrast to yeast, where as little as 60 bp of 3 ssDNA is sufficient to support HR (ref. 46) . Not mutually exclusive is the possibility that EXD2 could also augment resection efficiency under specific circumstances, for instance in the presence of modifications to the damaged DNA and/or polypeptides bound at the 5 ends. In line with this, we show that in vivo EXD2 depletion impairs shortrange resection.
Recently, it has been proposed that MRE11 may create multiple incisions on the DNA strand undergoing resection up to 300 bp distal to the break, which could allow for more efficient resection 21, 22 . Indeed, inhibition of MRE11's endonuclease activity seems to be dominant in promoting the generation of ssDNA over its exonuclease activity 23 . Thus, we postulate a model whereby EXD2 functionally collaborates with the resection machinery, most likely utilizing DNA nicks generated by MRE11's endonuclease activity 3 of the DSB. This would enhance the generation of ssDNA tails required for efficient homologous recombination (model Fig. 6d) .
In summary, our work identifies EXD2 as a critical factor in the maintenance of genome stability through HR-dependent repair of DSBs, including those induced by commonly used anticancer agents, such as IR or CPT. This highlights EXD2 itself and/or its enzymatic activity as a potential candidate for development of anticancer drugs.
METHODS
Methods and any associated references are available in the online version of the paper. . These cell lines were initially obtained as authenticated stocks from Life Technologies and ATCC, respectively, and were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) and standard antibiotics. U2OS cells stably expressing GFP-CtIP and U2OS cells harbouring the HR reporter DR-GFP were a gift from S. P. Jackson (Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, UK) and were maintained in media supplemented with 500 µg ml −1 G-418. The ER-AsiSI U2OS cell line 47 , a gift from G. Legube (Center for Integrative Biology, Université Paul Sabatier, France), was maintained in DMEM media without phenol red supplemented with 10% dialysed FBS (Life Technologies) and 1 µg ml −1 puromycin. Cell lines stably expressing Flag-HA-EXD2 WT or D108A-E110A fusion proteins were generated by transfection of U2OS cells with these plasmid constructs, followed by clonal selection of cells grown in media containing 0.5 µg ml −1 puromycin (Life Technologies). All cell lines have been verified mycoplasma free by a PCR-based test (Takara).
Plasmids. The open reading frame (ORF) of human EXD2 was purchased as a gateway entry clone in the pDONR221 plasmid backbone from DNASU Plasmid Repository (HsCD00295838). Discrepancies in the amino-acid sequence in comparison to the reference sequence for human EXD2 (NM_001193360.1) were corrected by site-directed mutagenesis. Site-directed mutagenesis was then employed to generate EXD2 D108A-E110A in pDONR221.
Flag-HA-EXD2 WT and D108A-E110A as well as GST-EXD2 WT and D108A-E110A plasmid constructs were generated by recombination of the WT or D108A-E110A EXD2 ORF in pDONR221 by LR Clonase reaction into either the pHAGE-N-Flag-HA destination vector (a gift from R. Chapman, The Wellcome Trust Centre for Human Genetics, University of Oxford, UK), or the pDESTpGEX6P-1 destination vector (a gift from C. Green, The Wellcome Trust Centre for Human Genetics, University of Oxford, UK), respectively. LR Clonase reactions were carried out using the Gateway LR Clonase II enzyme mix according to the instructions of the manufacturer (Life Technologies). The pCMV-I-Sce1 plasmid was a gift from V. Macaulay (Department of Oncology, University of Oxford, UK). pmCherry-C1 was obtained from Clontech. pX335-GFP plasmid (pX335 vector 48 containing PGK-EGFP-P2A-Neo-pA) was a gift from J. Riepsaame and M. de Bruijn (MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, UK).
His-EXD2 (Lys76-Ser589) construct was generated by cloning of truncated human EXD2 (Lys76-Ser589) in the expression vector pNIC28-Bsa4 (ref. 49), containing an amino-terminal His tag followed by a tobacco etch virus protease cleavage site. The construct was subsequently subjected to site-directed mutagenesis to introduce the D108A-E110A mutations. Plasmids were transfected into human cells using Lipofectamine 2000 (Life Technologies), according to the manufacturer's instructions.
Immunoblotting. Cell extracts were prepared by lysing cells in urea buffer (9 M urea, 50 mM Tris-HCl, pH 7.3, 150 mM β-mercaptoethanol) followed by sonication using a Soniprep 150 (MSE) probe sonicator. Proteins were resolved by SDS-PAGE and transferred to polyvinylidene difluoride. Immunoblots were carried out using the indicated antibodies (see Supplementary Table 1) .
Cell survival assay. Alamar Blue survival assays were Carried out in accordance with the recommendations of the manufacturer (Life Technologies). Briefly, 300 cells per well in 96-well plates were left untreated or treated with indicated doses of CPT, ionizing radiation, phleomycin or olaparib and incubated for 7 days. Alamar Blue reagent (Life Technologies) was added to each well and fluorometric measurements made after 2 h incubation at 37 • C.
RNAi treatment. siRNAs used in this study are listed in Supplementary Table 2 . ONTARGETplus non-targeting pool or siRNA targeting luciferase 50 were used as control siRNAs where appropriate.
Immunofluorescence microscopy. Antibodies employed for immunofluorescence are listed in Supplementary Table 1. For visualization of RPA foci, cells were pre-extracted on ice for 2 min (10 mM PIPES, pH 6.8, 300 mM sucrose, 100 mM NaCl, 1.5 mM MgCl 2 and 0.5% Triton-X100) and fixed with 4% paraformaldehyde in PBS for 10 min at room temperature. Coverslips were washed 3× in PBS and blocked in 10% FBS in PBS for 30 min before incubation with primary antibody in 0.1% FBS in PBS for 1 h at room temperature. Unbound primary antibody was removed by washing for 4 × 5 min in PBS at room temperature followed by incubation with the indicated secondary antibody for 45 min at room temperature. Slides were then washed for 4 × 5 min in PBS before mounting with VECTASHIELD mounting medium (Vector Laboratories) with DAPI.
To visualize ssDNA foci, the same protocol as for RPA focus staining was used, preceded by treatment of cells growing on coverslips with 10 µM BrdU for 24 h before fixation.
To visualize RAD51 foci, cells grown on coverslips were fixed with 4% paraformaldehyde in PBS for 10 min at room temperature followed by permeabilization with 0.5% Triton-X100 in PBS for 10 min at room temperature. Cells were then blocked, incubated with primary and secondary antibodies and mounted for analysis as described above. Confocal microscopy was carried out using a Zeiss LSM 510 laser scanning confocal microscope with Zen 2009 software using a ×63 objective. Image analysis was carried out with FIJI (ImageJ) software.
Microirradiation experiments. Induction of localized DSBs in human cells was carried out as described previously 43 . Briefly, cells were grown on coverslips and pre-treated for 24 h with 10 µM BrdU before microirradiation. To induce localized DSBs, the medium was removed and cells were washed once in PBS, with subsequent removal of excess PBS. Isopore membrane filters (Millipore TMTP02500, 0.5 µM pore size) were placed on top of the coverslips and cells were exposed to 30 J m −2 ultraviolet C light using a Stratagene UV Stratalinker 2400. Membrane filters were removed and media placed back on the cells, which were allowed to recover for the indicated times before fixation. Cells were fixed, permeabilized and blocked as per RAD51 focus staining (described above). Cells expressing GFP-CtIP were stained for GFP (using the GFP-Booster reagent, ChromoTek, 1:200) and γ H2AX using the indicated secondary antibody. Images of microirradiated cells were acquired using a DeltaVision DV Elite microscope using a ×40 objective. Image analysis was carried out with FIJI (ImageJ) and Huygens Professional (Scientific Volume Imaging) software. U2OS cells were stained for MRE11 and γ H2AX and visualized on a Zeiss LSM 510 confocal microscope using a ×40 objective. Image analysis was carried out using FIJI (ImageJ).
Immunoprecipitation experiments.
Lysates for co-immunoprecipitation experiments were prepared as follows: cells were washed twice in PBS and then lysed in IP buffer (100 mM NaCl, 0.2% IGEPAL CA-630, 1 mM MgCl 2 , 10% glycerol, 5 mM NaF, 50 mM Tris-HCl, pH 7.5), supplemented with complete EDTA-free protease inhibitor cocktail (Roche) and 25 U ml −1 Benzonase (Novagen). After Benzonase digestion, the NaCl and EDTA concentrations were adjusted to 200 mM and 2 mM, respectively, and lysates cleared by centrifugation (16,000g for 25 min). Lysates were then incubated with 20 µl of GFP-Trap agarose beads (ChromoTek) blocked with 5% BSA in IP lysis buffer for 1 h at 4 • C in the case of GFP-Trap IPs or with 20 µl of anti-Flag M2 affinity gel in the case of Flag IPs for 2 h with end-to-end mixing at 4 • C. Complexes were washed extensively in IP buffer (including 200 mM NaCl and 2 mM EDTA) before elution. In the case of GFP-Trap IPs, beads were resuspended in ×2 SDS sample buffer and boiled for 3 min before centrifugation at 5,000g for 5 min. The resultant supernatant fraction was retained as the eluate. In the case of Flag IPs, beads were incubated for 30 min with gentle agitation at 4 • C in IP buffer supplemented with 400 µM ×3 Flag peptide (Sigma), followed by centrifugation at 5,000g for 5 min. The resultant supernatant fraction was collected as eluate.
For mass spectrometry analyses, eluates from IP experiments were analysed by the Mass Spectrometry Laboratory (IBB PAS) using the Thermo Orbitrap Velos system and protein hits were identified by MASCOT.
Chromosomal aberrations. Cells were prepared for analyses of chromosomal aberrations as described previously 51 . Briefly, colcemid (0.1 µg ml −1 ) was added 4 h before cell harvesting. Cells were trypsinized and incubated in 0.075 M KCl for 20 min. After fixing in methanol:acetic acid (3:1) for 30 min, cells were dropped onto slides and stained with Leishman's solution for 2 min. Slides were then coded and scored blind to the observer.
Homologous recombination DR-GFP assay. 48 h after siRNA transfection, U2OS DR-GFP cells 16 were co-transfected using Amaxa nucleofection with an I-SceI expression vector (pCMV-I-SceI) and a vector expressing mCherry fluorescent protein (pmCherry-C1). 24 h after I-SceI transfection cells were collected and analysed by flow cytometry (CyAn ADP Analyzer, Beckman Coulter). The percentage of GFP-positive cells among transfected cells (mCherry-positive cells) was determined using Summit 4.3 software. The control siRNA treated sample was set as 100%. Statistical significance was determined with Student's t-test.
Recombinant protein purification. GST-tagged proteins were purified as described 51 with some modifications. Briefly, GST protein expression was induced with 0.1 mM IPTG (isopropyl-β-D-thiogalactoside) (Sigma-Aldrich) at 16 • C for 18 h. Bacteria were collected by centrifugation and resuspended in lysis buffer containing 50 mM Tris-HCl at pH 8.0, 150 mM NaCl, 2 mM EDTA, 1 mM dithiothreitol (DTT), 1% Triton-X100, and protease inhibitors. Lysates were sonicated and cleared by centrifugation. Supernatants were incubated with Glutathione HiCap Matrix (Qiagen) for 2 h with rotation at 4 • C. Beads were washed with lysis buffer containing increasing NaCl concentration, elution buffer (50 mM Tris-HCl at pH 7.0, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.2% Triton-X100), resuspended in elution buffer supplemented with PreScission Protease (50 units ml −1 ) (GE Healthcare) and incubated for 18 h with rotation at 4 • C. Eluates were dialysed to buffer containing 20 mM HEPES-KOH at pH 7.2, 100 mM NaCl, 1 mM DTT and 10% glycerol, aliquoted and stored at −80 • C.
His-EXD2 (Lys76-Ser589) protein and the corresponding D108A-E110A mutant protein were expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells 49 grown in TB medium and induced with 0.5 mM IPTG at 18 • C overnight. Cells were collected by centrifugation and resuspended in a lysis buffer containing 50 mM HEPES, pH 7.5, 500 mM NaCl, 10 mM imidazole, 5% glycerol, 1 mM tris(2-carboxyethyl)phosphine (TCEP), 0.5% Triton, supplemented with a protease inhibitor mixture (Roche Applied Science). The cells were sonicated, polyethyleneimine was added to 0.15% (w/v) from a 5% pH 7.5 stock solution, and lysates were cleared by centrifugation. The supernatant was applied to a Ni-Sepharose resin, washed with 50 mM HEPES, pH 7.5, 300 mM NaCl, 45 mM imidazole, 5% glycerol, 1 mM TCEP, 0.5% Triton, 1 mM phenylmethyl sulphonyl fluoride (PMSF) and 2 mM benzamidine, and eluted in 50 mM HEPES, pH 7.5, 300 mM NaCl, 300 mM imidazole, 5% glycerol, 1 mM TCEP, 1 mM PMSF and 2 mM benzamidine. The eluate was further purified on two sequential Superdex S200 gel-filtration columns in GF buffer (50 mM HEPES, pH 7.5, 500 mM NaCl, 5% glycerol, 1 mM TCEP, 0.1% Triton, 1 mM PMSF and 2 mM benzamidine). At each stage the presence of protein was confirmed on an InstantBlue-stained SDS-PAGE gel, and the identity of the final preparation was confirmed using electrospray ionization-time of flight mass spectrometry. Mass spectrometry indicated that both the WT and D108A-E110A mutant proteins had a lower mass than predicted. Analysis using PAWS software (Genomic Solutions) suggests that the proteins were lacking amino acids 565-589 at the carboxy-terminus, probably due to proteolysis resulting in an EXD2 protein (WT or mutant) that consisted of amino acids Lys76-Val564. Recombinant human MRN was purified as previously described 52 .
In vitro nuclease assay. Sequences of DNA oligonucleotides used are listed in Supplementary Table 3 . To generate 3 end labelled substrates, the indicated ssDNA oligonucleotide was labelled using [α-
32 P] dATP and TdT enzyme (New England Biolabs). To generate 5 end labelled substrates, the indicated ssDNA oligonucleotide was labelled using [γ -
32 P] dATP and T4 polynucleotide kinase (New England Biolabs). To obtain dsDNA substrates, complementary ssDNA oligonucleotides (as indicated in Supplementary Table 3) were mixed in an equimolar ratio and annealed by heating at 100 • C for 5 min followed by gradual cooling to room temperature. Where indicated DNA substrates with biotin label at the 3 end were used and pre-incubated for 5 min at room temperature with a tenfold molar excess of streptavidin (Sigma).
Exonuclease assays were performed as described 53 with some modifications. Briefly, reactions were carried out in a buffer containing 20 mM HEPES-KOH, pH 7.5, 50 mM KCl, 0.5 mM DTT, 10 mM MnCl 2 , 0.05% Triton-X, 0.1 mg ml −1 BSA, 5% glycerol and 50 ng of EXD2 protein, initiated by adding the indicated amount of substrate and incubated at 37 • C for the indicated lengths of time. Reactions were stopped by addition of EDTA to a final concentration of 20 mM and 1/5 volume of formamide. The samples were resolved on denaturing 20% polyacrylamide TBE-urea gels. Gels were fixed, dried and visualized using a Typhoon FLA 9500 instrument (GE Healthcare).
Thin layer chromatography was performed as described 54 . Briefly, exonuclease reactions were terminated by addition of stop solution (2% SDS, 120 mM EDTA) and 1 µl of reaction mixtures was spotted on polyethylenimine cellulose thin layer plates (Merck). Plates were developed in 1.0 M sodium formate at pH 3.4 and subsequently visualized using a Typhoon FLA 9500 instrument (GE Healthcare).
The X174 circular single-stranded substrate (30 µM nucleotides) from New England Biolabs was incubated with MRN complex (50 nM) in the presence or absence of His-EXD2 (Lys76-Ser589) (350 nM) or corresponding mutant protein in buffer containing 20 mM HEPES-KOH, pH 7.5, 50 mM KCl, 0.5 mM DTT, 5 mM MnCl 2 , 0.05% Triton-X, 0.1 mg ml −1 BSA, 5% glycerol and 1 mM ATP. After 2 h the reaction was stopped by adding 1/5 volume of stop solution (2% SDS, 50 mM EDTA). Reactions were resolved on agarose gels, stained with SYBR Gold and visualized using a Typhoon FLA 9500 instrument (GE Healthcare).
ER-AsiSI resection assay.
The level of resection adjacent to a specific DSB (Chr 1: 89231183) was measured as described 40 with some modifications. Briefly ER-AsiSI U2OS cells were treated with 300 nM of 4-OHT (Sigma) for 1 h to allow the AsiSI enzyme to enter the nucleus and induce DSBs. Cells were then collected and genomic DNA was extracted as previously described 40 . Genomic DNA was then digested with the BsrGI enzyme or mock digested and was used as a template for qPCR performed using iTaq Universal SYBR Green Mix (Bio-Rad) and a Rotor-Gene (Corbett Research) qPCR system. Primers used are listed in Supplementary Table 4 (ref. 40) . The percentage of ssDNA was calculated as previously described 40 . All data were then related to the control siRNA treated sample, which was set to 100%. Statistical significance was determined with Student's t-test. DNA oligonucleotides were purchased from IDT and cloned into pX335-GFP vector 48 to generate targeting constructs that were subsequently co-transfected in an equimolar ratio into HeLa cells using Lipofectamine. 24 h after transfection, cells were sorted using a MoFlo cell sorter (Beckman Coulter) for cells expressing Cas9 nickase (GFP-positive cells) and left to recover for 6 days before sorting for single cells and allowing colonies to form. EXD2 expression was analysed by western blotting. Two clones showing loss of all detectable EXD2 were selected for subsequent analysis.
Generation of EXD2
Chromatin fractionation. HeLa cells were treated with 500 µM phleomycin for 1 h, washed with ice cold PBS and scraped into PBS, and the chromatin fractionation was performed as described 56, 57 . Briefly, cells were resuspended in buffer A (10 mM HEPES-KOH at pH 7.9, 10 mM KCl, 1.5 MgCl 2 , 340 mM sucrose, 10% glycerol, 1 mM DTT, protease inhibitors) and Triton-X100 was added to final concentration 0.1%. After 5 min incubation on ice, nuclei were spun down at 1,300g for 4 min. Pelleted nuclei were washed with buffer A, resuspended in buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, protease inhibitors) and lysed for 20 min on ice before centrifugation at 1,700g for 5 min. The supernatant (nuclear soluble fraction) was saved, and the pellet (chromatin fraction) was washed with buffer B, resuspended in urea buffer (9 M urea, 50 mM Tris-HCl, pH 7.3) and sonicated.
Statistics and reproducibility. Microsoft Excel or Prism 6 software was used to perform statistical analyses. Detailed information (statistical tests used, number of independent experiments, P-values) are listed in individual figure legends. All experiments were repeated at least twice unless stated otherwise. Alignment of the partial amino acid sequences of EXD2 proteins from various vertebrate organisms (human, mouse, chicken and xenopus are depicted) with a partial amino acid sequence of the exonuclease domain of human Werner helicase protein (WRN). Highly conserved residues shown to mediate the exonuclease activity of WRN protein which are also conserved in human EXD2 and its vertebrate homologues are indicated with red arrows. Coomassie stained SDS-PAGE gel of EXD2 WT or D108A E110A mutant protein ectopically expressed in E. coli and purified to homogeneity for use in in vitro biochemistry experiments. InstantBlue stained SDS-PAGE gel of the truncated EXD2 proteins (WT and D108A E110A mutant) used in this study. Mass spectrum of truncated EXD2 (K76 -V564) WT protein confirming sample purity. Mass spectrum of truncated EXD2 (K76 -V564) D108A E110A protein confirming sample purity. f) 5' radiolabeled ssDNA or dsDNA substrate (10 nM molecules) was incubated for indicated amounts of time with EXD2 WT (K76 -V564) or EXD2 (K76 -V564) D108A E110A (EXD2 mut) protein (100 nM). Samples were resolved on a 20% TBE-Urea polyacrylamide gel and visualised by phosphorimaging. This experiment was carried out two times independently. 
EXD2
Supplementary Figure 7 Original uncropped images of western blots.
